In a recent investigation, Omar et al. developed α1-acid glycoprotein (AGP)-conjugated HA (AGP-HA NPs) to modulate the responsiveness of breast cancer towards chemotherapy and inhibit the spread of breast tumors. The gene discussed is ATP5MK; the disease is breast carcinoma.